Emerging Biomarkers in Hypertension

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

First of all to evaluate the relationship between non-conventional biomarkers and essential hypertension; then to evaluate the effects of various anti-hypertensive drugs on blood pressure control and non-conventional biomarkers in naive hypertensive patients

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Pavia
• Collaborator: IRCCS Policlinico S. Matteo
• Treatments: Antihypertensive Agents

Criteria

Inclusion Criteria:

• essential hypertension

• naive to treatment

• < 65 years

Exclusion Criteria:

• secondary hypertension

• previous cardiovascular events